Use of teicoplanin in community medicine.
Administration of parenteral antibiotics to outpatients is increasingly used to reduce hospital costs, to reduce loss of earnings for the patient and to improve the quality of life in patients requiring prolonged antibiotic treatment. The glycopeptides are required for treatment of infections caused by methicillin resistant staphylococci and some enterococci, or for treatment of patients allergic to beta-lactam agents. For home therapy, teicoplanin has some advantages over vancomycin in that it requires only once-daily bolus administration, does not necessitate monitoring of serum concentrations and offers the choice of intravenous or intramuscular administration. Teicoplanin has been used to complete treatment of endocarditis at home in selected patients, streptococcal disease being the most suitable form of endocarditis for this treatment. In open trials, teicoplanin has been found effective in home therapy of osteomyelitis but, as with other agents, prolonged dosage can be associated with adverse effects. It has also been used for home treatment of infections of the respiratory tract, intravascular catheters and soft tissue. Despite its higher acquisition costs, teicoplanin is to be preferred over vancomycin because of the reduced administration and assay costs and fewer adverse effects.
Department of Clinical Microbiology, University College Hospital, London, UK.
A P
AP
Wilson
R N
RN
Grüneberg
D000553:Ambulatory Care / Q000191:economics; D001170:Arthritis, Infectious / Q000188:drug therapy; D001424:Bacterial Infections / Q000188:drug therapy / Q000191:economics; D003154:Community Medicine / Q000191:economics; D003363:Cost Control; D004352:Drug Resistance, Microbial; D004696:Endocarditis / Q000188:drug therapy; D006801:Humans; D009503:Neutropenia / Q000188:drug therapy; D010019:Osteomyelitis / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D018461:Soft Tissue Infections / Q000188:drug therapy; D017334:Teicoplanin / Q000191:economics / Q000627:therapeutic use
D017334:Teicoplanin